Healthcare -
Biotechnology - NYSE - US
$ 4.9993
2.24 %
$ 69 M
Market Cap
-1.18
P/E
ANVS - TOTAL CURRENT LIABILITIES
Total Current Liabilities ANVS - Annovis Bio, Inc.
4.28 M
LAST VALUE
68.54%
2 YEAR CAGR
49.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR